Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/176033
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Troncoso Mariño, Amelia | - |
dc.contributor.author | Roso Llorach, Albert | - |
dc.contributor.author | López Jiménez, Tomás | - |
dc.contributor.author | Villen, Noemí | - |
dc.contributor.author | Amado Guirado, Ester | - |
dc.contributor.author | Fernández Bertolin, Sergio | - |
dc.contributor.author | Carrasco Ribelles, Lucía A. | - |
dc.contributor.author | Borràs Andrés, Josep Maria | - |
dc.contributor.author | Violán, Concepción | - |
dc.date.accessioned | 2021-04-06T12:58:49Z | - |
dc.date.available | 2021-04-06T12:58:49Z | - |
dc.date.issued | 2021-02-11 | - |
dc.identifier.uri | http://hdl.handle.net/2445/176033 | - |
dc.description.abstract | Aging, multimorbidity, and polypharmacy are associated with medication-related problems (MRPs). This study aimed to assess the association that multimorbidity and mortality have with MRPs in older people over time. We followed multimorbid, older (65-99 years) people in Catalonia from 2012 to 2016, using longitudinal data and Cox models to estimate adjusted hazard ratios (HR). We reviewed electronic health records to collect explanatory variables and MRPs (duplicate therapy, drug-drug interactions, potentially inappropriate medications (PIM), and contraindicated drugs in chronic kidney disease (CKD) or liver disease). There were 723,016 people (median age: 74 years; 58.9% women) who completed follow-up. We observed a significant (p < 0.001) increase in the proportion with at least one MRP (2012: 66.9% to 2016: 75.5%); contraindicated drugs in CKD (11.1 to 18.5%) and liver disease (3.9 to 5.3%); and PIMs (62.5 to 71.1%), especially drugs increasing fall risk (67.5%). People with ≥10 diseases had more MRPs (in 2016: PIMs, 89.6%; contraindicated drugs in CKD, 34.4%; and in liver disease, 9.3%). All MRPs were independently associated with mortality, from duplicate therapy (HR 1.06; 95% confidence interval (CI) 1.04-1.08) to interactions (HR 1.60; 95% CI 1.54-1.66). Ensuring safe pharmacological treatment in elderly, multimorbid patient remains a challenge for healthcare systems. | - |
dc.format.extent | 14 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | MDPI | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.3390/jcm10040709 | - |
dc.relation.ispartof | Journal of Clinical Medicine, 2021, vol. 10, num. 4 | - |
dc.relation.uri | https://doi.org/10.3390/jcm10040709 | - |
dc.rights | cc by (c) Troncoso Mariño et al., 2021 | - |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
dc.source | Articles publicats en revistes (Ciències Clíniques) | - |
dc.subject.classification | Morbiditat | - |
dc.subject.classification | Persones grans | - |
dc.subject.classification | Interaccions dels medicaments | - |
dc.subject.classification | Catalunya | - |
dc.subject.other | Morbidity | - |
dc.subject.other | Older people | - |
dc.subject.other | Drug interactions | - |
dc.subject.other | Catalonia | - |
dc.title | Medication-Related Problems in Older People with Multimorbidity in Catalonia: A Real-World Data Study with 5 Years’ Follow-Up | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.date.updated | 2021-03-25T08:29:50Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 33670201 | - |
Appears in Collections: | Articles publicats en revistes (Ciències Clíniques) Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
jcm-10-00709-v2.pdf | 839.92 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License